ODILIA™ is a science-backed prebiotic from Opuntia cladode co-products, standardized in polysaccharides and piscidic acid.
Backed by a randomized, double-blind, placebo-controlled human study and tested at just 300 mg/day, it supports microbiota balance and the gut–brain–muscle axis, helping everyday resilience to stress and fatigue.
Designed with a circular, co-product valorization approach, ODILIA™ offers an efficient, low-dose solution for next-gen gut-health and wellbeing formulations.
